BGTBio-Gene Technology Limited

BGT Stock Price, Valuation & Chart | Bio-Gene Technology Limited

Compare

$0.020+0.00 (+5.88%)

At close · 02 Sept 2026, 04:12 am

Sector: Healthcare BGT intrinsic value BGT calculated fair value vs price Website

Overview Financials Dividends Ratios

BGT Historical price chart

BGT Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization4.86M

PE Ratio-2.53

EPS-0.01

Trading Volume54.99K

Today's High/Low0.02/0.02

Dividend Yield0.00

52 Week High/Low0.06/0.02

Shares Outstanding270.24M

BGT Financial Statement

BGT Analyst ratings

Buy

Strong buy

Buy

Hold

Sell

Strong sell

Based on 0 analysts giving stock ratings to BGT in the past 3 months.

BGT Analysis & performance metrics

BGT Company profile

Bio-Gene Technology Limited, an agtech development company, engages in developing and commercializing insecticides/pesticides for animal health, crop protection, public…

Bio-Gene Technology Limited, an agtech development company, engages in developing and commercializing insecticides/pesticides for animal health, crop protection, public health, and consumer applications in Australia. Its lead products include Flavocide, a beta-triketone insecticide product; and Qcide, a natural oil extracted from a cultivar of eucalyptus cloeziana. The company has a…

BGT Management team

Name

Position

Edmond Tern B.A., CPACFO

Chief Financial Officer & Company Secretary

Timothy Owen Grogan B.Sc., LLBCEO

MD, Chief Executive Officer & Director

Peter Donald May AFA1M, AFAIM, GAICD, M.B.A., MBACTO

Executive Director of Research & Development and Executive Director

Name

Position

Edmond Tern B.A., CPACFO

Chief Financial Officer & Company Secretary

Timothy Owen Grogan B.Sc., LLBCEO

MD, Chief Executive Officer & Director

Peter Donald May AFA1M, AFAIM, GAICD, M.B.A., MBACTO

Executive Director of Research & Development and Executive Director

Management Team

Edmond Tern B.A., CPACFO

Chief Financial Officer & Company Secretary

Timothy Owen Grogan B.Sc., LLBCEO

MD, Chief Executive Officer & Director

Peter Donald May AFA1M, AFAIM, GAICD, M.B.A., MBACTO

Executive Director of Research & Development and Executive Director

Management

Edmond Tern B.A., CPACFO

Chief Financial Officer & Company Secretary

Timothy Owen Grogan B.Sc., LLBCEO

MD, Chief Executive Officer & Director

Peter Donald May AFA1M, AFAIM, GAICD, M.B.A., MBACTO

Executive Director of Research & Development and Executive Director

Total 3 executives

BGT Frequently asked questions

What is Bio-Gene Technology Limited (BGT) Stock Price?

Current stock price of Bio-Gene Technology Limited (BGT) stock is $0.020. The stock price is +5.88% higher in the session. The intraday range can be seen from this page. Volume of Bio-Gene Technology Limited (BGT) stock is 54.99K.

Last updated at 02 Sept 2026, 04:12 am.

Why is the Bio-Gene Technology Limited (BGT) stock price going up or down today?

The stock price of Bio-Gene Technology Limited (BGT) can change with earnings, company news, and overall market sentiment. Bio-Gene Technology Limited operates in the Healthcare / Unknown market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Bio-Gene Technology Limited stock expensive at its current price?

Whether Bio-Gene Technology Limited looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for BGT on this page is -2.53. EPS on this page is -0.01. Compare those figures with peers and growth expectations before deciding if the current Bio-Gene Technology Limited price is justified.

How has the stock price of Bio-Gene Technology Limited (BGT) performed historically?

Historical performance for Bio-Gene Technology Limited (BGT) is shown on the price chart on this page. Review multi-period moves alongside volume to see how BGT reacted to past earnings and market events.

Should I buy Bio-Gene Technology Limited (BGT) stock, at this price?

Buying Bio-Gene Technology Limited (BGT) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.